Shares of Dr Reddy Laboratories were last trading 11.37 per cent lower at Rs 4,794.35 on the BSE.Share price of Dr Reddy's Laboratories decreased more than 11 percent on Tuesday, July 27, after the business revealed its April-June quarter results for the fiscal year 2021-22.
On Tuesday, Dr Reddy's Labs opened on the BSE at Rs 5,421, inching to an intra day high of Rs 5,445, and an intra day low of Rs 4,786.26, in the trading session up until now.
The pharmaceutical company reported a net earnings of Rs 570.8 crore on a combined basis in the first quarter of the present financial, down 1.5 per cent compared to Rs 579.3 crore in the year-ago period.The Hyderabad-based pharma company's income from operations increased 11.4 per cent to Rs 4919.4 crore in the Juen quarter, compared to Rs 4,417.6 crore in the corresponding quarter last year.The company's sales in India jumped 69 per cent to Rs 1,060 crore tracking a low base in the year-ago duration.
Throughout the quarter, the topline performance of the business was driven by domestic and European operations, according to a regulative filing by the company to the stock exchanges.The earnings before interest, tax, depreciation and amortization (EBITDA) declined 12.3 percent to Rs 1,019 crore, and the margin slid by 560 bps to 20.7 percent from the year-ago period.On the NSE, Dr Reddy's Labs opened at Rs 5,438, and signed up an intra day high of Rs 5,444.95 and an intra day low of Rs 4,780, in the session up until now.
It was last trading 11.61 percent lower at Rs 4,783.05 on the NSE.Shares of Dr Reddy Laboratories were last trading 11.37 per cent lower at Rs 4,794.35 on the BSE.